Connection

ROSEMARIE SCHMANDT to Receptor, Fibroblast Growth Factor, Type 4

This is a "connection" page, showing publications ROSEMARIE SCHMANDT has written about Receptor, Fibroblast Growth Factor, Type 4.
  1. Identification of FGFR4 as a potential therapeutic target for advanced-stage, high-grade serous ovarian cancer. Clin Cancer Res. 2013 Feb 15; 19(4):809-20.
    View in: PubMed
    Score: 0.107
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.